1. Home
  2. BCLI vs BNRG Comparison

BCLI vs BNRG Comparison

Compare BCLI & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • BNRG
  • Stock Information
  • Founded
  • BCLI 2000
  • BNRG 2012
  • Country
  • BCLI United States
  • BNRG Israel
  • Employees
  • BCLI N/A
  • BNRG N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • BNRG
  • Sector
  • BCLI Health Care
  • BNRG
  • Exchange
  • BCLI Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • BCLI 9.9M
  • BNRG 14.7M
  • IPO Year
  • BCLI N/A
  • BNRG 2022
  • Fundamental
  • Price
  • BCLI $1.73
  • BNRG $1.45
  • Analyst Decision
  • BCLI Strong Buy
  • BNRG
  • Analyst Count
  • BCLI 1
  • BNRG 0
  • Target Price
  • BCLI $30.00
  • BNRG N/A
  • AVG Volume (30 Days)
  • BCLI 41.1K
  • BNRG 396.4K
  • Earning Date
  • BCLI 03-31-2025
  • BNRG 03-03-2025
  • Dividend Yield
  • BCLI N/A
  • BNRG N/A
  • EPS Growth
  • BCLI N/A
  • BNRG N/A
  • EPS
  • BCLI N/A
  • BNRG N/A
  • Revenue
  • BCLI N/A
  • BNRG $41,000.00
  • Revenue This Year
  • BCLI N/A
  • BNRG N/A
  • Revenue Next Year
  • BCLI N/A
  • BNRG N/A
  • P/E Ratio
  • BCLI N/A
  • BNRG N/A
  • Revenue Growth
  • BCLI N/A
  • BNRG N/A
  • 52 Week Low
  • BCLI $1.05
  • BNRG $0.60
  • 52 Week High
  • BCLI $11.85
  • BNRG $4.11
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 40.62
  • BNRG 51.50
  • Support Level
  • BCLI $1.69
  • BNRG $1.02
  • Resistance Level
  • BCLI $1.93
  • BNRG $1.43
  • Average True Range (ATR)
  • BCLI 0.11
  • BNRG 0.18
  • MACD
  • BCLI -0.00
  • BNRG 0.01
  • Stochastic Oscillator
  • BCLI 16.67
  • BNRG 63.24

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is an Israel-based company. It is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: